ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,650,000 | +22.9% | 21,207 | -10.4% | 0.07% | +22.2% |
| Q2 2021 | $2,970,000 | -7.4% | 23,667 | 0.0% | 0.05% | -15.6% |
| Q1 2021 | $3,209,000 | +6.0% | 23,667 | 0.0% | 0.06% | -1.5% |
| Q4 2020 | $3,028,000 | +11.3% | 23,667 | -2.1% | 0.06% | -3.0% |
| Q3 2020 | $2,720,000 | +13.4% | 24,167 | -4.0% | 0.07% | +4.7% |
| Q2 2020 | $2,398,000 | +2.0% | 25,167 | -3.8% | 0.06% | -17.9% |
| Q1 2020 | $2,352,000 | +35.5% | 26,167 | -20.1% | 0.08% | +66.0% |
| Q4 2019 | $1,736,000 | +34.2% | 32,742 | 0.0% | 0.05% | +23.7% |
| Q3 2019 | $1,294,000 | -3.8% | 32,742 | 0.0% | 0.04% | -7.3% |
| Q2 2019 | $1,345,000 | -11.8% | 32,742 | 0.0% | 0.04% | -16.3% |
| Q1 2019 | $1,525,000 | +6.9% | 32,742 | 0.0% | 0.05% | -9.3% |
| Q4 2018 | $1,426,000 | -23.9% | 32,742 | 0.0% | 0.05% | -10.0% |
| Q3 2018 | $1,874,000 | +17.9% | 32,742 | 0.0% | 0.06% | +11.1% |
| Q2 2018 | $1,589,000 | +24.1% | 32,742 | 0.0% | 0.05% | +10.2% |
| Q1 2018 | $1,280,000 | -7.9% | 32,742 | 0.0% | 0.05% | -5.8% |
| Q4 2017 | $1,390,000 | +13.7% | 32,742 | 0.0% | 0.05% | +8.3% |
| Q3 2017 | $1,222,000 | +22.8% | 32,742 | 0.0% | 0.05% | +26.3% |
| Q2 2017 | $995,000 | +14.8% | 32,742 | 0.0% | 0.04% | +11.8% |
| Q1 2017 | $867,000 | +3.7% | 32,742 | 0.0% | 0.03% | -2.9% |
| Q4 2016 | $836,000 | -29.5% | 32,742 | 0.0% | 0.04% | -28.6% |
| Q3 2016 | $1,185,000 | +6.5% | 32,742 | 0.0% | 0.05% | 0.0% |
| Q2 2016 | $1,113,000 | +28.8% | 32,742 | 0.0% | 0.05% | +28.9% |
| Q1 2016 | $864,000 | -49.4% | 32,742 | -6.6% | 0.04% | -51.9% |
| Q4 2015 | $1,709,000 | +3969.0% | 35,042 | +2002.1% | 0.08% | +3850.0% |
| Q3 2015 | $42,000 | -20.8% | 1,667 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $53,000 | -15.9% | 1,667 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $63,000 | -3.1% | 1,667 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $65,000 | +30.0% | 1,667 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $50,000 | -12.3% | 1,667 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $57,000 | – | 1,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |